Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Non-cash Items (2017 - 2025)

Oramed Pharmaceuticals filings provide 9 years of Non-cash Items readings, the most recent being $5.0 million for Q4 2025.

  • Quarterly Non-cash Items rose 249.52% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 249.52% year-over-year, with the annual reading at $5.0 million for FY2025, 4031.97% up from the prior year.
  • Non-cash Items hit $5.0 million in Q4 2025 for Oramed Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $5.0 million in Q4 2025 and bottomed at $47000.0 in Q4 2022.
  • Average Non-cash Items over 5 years is $2.1 million, with a median of $1.5 million recorded in 2023.
  • The largest annual shift saw Non-cash Items soared 3047.71% in 2023 before it decreased 2.51% in 2024.
  • Oramed Pharmaceuticals' Non-cash Items stood at $859447.0 in 2021, then crashed by 94.53% to $47000.0 in 2022, then soared by 3047.71% to $1.5 million in 2023, then fell by 2.51% to $1.4 million in 2024, then soared by 249.52% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Non-cash Items are $5.0 million (Q4 2025), $1.4 million (Q4 2024), and $4.0 million (Q3 2024).